Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (13)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Bihoreau, M.-T.
Right arrow Articles by Gretz, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bihoreau, M.-T.
Right arrow Articles by Gretz, N.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2002, Vol. 11, No. 18 2165-2173
© 2002 Oxford University Press

Characterization of a major modifier locus for polycystic kidney disease (Modpkdr1) in the Han:SPRD(cy/+) rat in a region conserved with a mouse modifier locus for Alport syndrome

Marie-Thérèse Bihoreau1,*, Natalia Megel2, Joanna H. Brown1, Bettina Kränzlin2, Laurence Crombez1, Yulia Tychinskaya2, John Broxholme1, Susanne Kratz2, Volker Bergmann3, Sigrid Hoffman2, Dominique Gauguier1 and Norbert Gretz2

1The Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK, 2Medical Research Centre, Klinikum Mannheim, University of Heidelberg, D-68167 Mannheim, Germany and 3Institute of Veterinary Pathology, Free University of Berlin, D-14163 Berlin, Germany

Received May 9, 2002; Accepted June 28, 2002

The genetic analysis of rodent disease models provides a powerful tool to investigate how modifier loci cause variation in the phenotypic expression of a disease. In order to test the existence of modifier loci influencing polycystic kidney disease (PKD) phenotypes, we derived a backcross between PKD susceptible Han:SPRD(cy/+) and control Brown Norway (BN) rats, and performed a whole-genome scan in 182 PKD affected hybrids showing different grades of disease severity. The genetic dissection of PKD in the cross allowed us to detect a modifier locus, Modpkdr1, on rat chromosome 8 that controls PKD severity, kidney mass and plasma urea concentration. Results from database searches and computational analyses demonstrated that the Modpkdr1 locus shows strong evidence of synteny conservation with human and mouse chromosomal regions controlling kidney diseases, including disease progression of Alport syndrome. Comparative genome mapping also provided an inventory of potential candidate genes for modifier(s) of PKD. Analyses of the coding regions for four strong candidates (Ctsh, Bcl2a1, Trpc1 and Slc21a2) in (cy/+), BN and Lewis rat strains did not reveal sequence variants that could be associated with PKD. The characterization of Modpkdr1 may provide new insights into modulating mechanisms involved in the pathogenesis of PKD that could delay disease progression in humans. It may also have strong implications in the identification of pathophysiological factors common to different renal disorders.

* To whom correspondence should be addressed. Tel: +44 1865287648; Fax: +44 1865287533; Email: bihoreau{at}well.ox.ac.uk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
A. Pierides, K. Voskarides, Y. Athanasiou, K. Ioannou, L. Damianou, M. Arsali, M. Zavros, M. Pierides, V. Vargemezis, C. Patsias, et al.
Clinico-pathological correlations in 127 patients in 11 large pedigrees, segregating one of three heterozygous mutations in the COL4A3/ COL4A4 genes associated with familial haematuria and significant late progression to proteinuria and chronic kidney disease from focal segmental glomerulosclerosis
Nephrol. Dial. Transplant., April 8, 2009; (2009) gfp158v1.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
B. Tazon-Vega, M. Vilardell, L. Perez-Oller, E. Ars, P. Ruiz, O. Devuyst, X. Lens, P. Fernandez-Llama, J. Ballarin, and R. Torra
Study of candidate genes affecting the progression of renal disease in autosomal dominant polycystic kidney disease type 1
Nephrol. Dial. Transplant., June 1, 2007; 22(6): 1567 - 1577.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. H. Brown, M.-T. Bihoreau, S. Hoffmann, B. Kranzlin, I. Tychinskaya, N. Obermuller, D. Podlich, S. N. Boehn, P. J. Kaisaki, N. Megel, et al.
Missense Mutation in Sterile {alpha} Motif of Novel Protein SamCystin is Associated with Polycystic Kidney Disease in (cy/+) Rat
J. Am. Soc. Nephrol., December 1, 2005; 16(12): 3517 - 3526.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Z. Zheng, K. M. Schmidt-Ott, S. Chua, K. A. Foster, R. Z. Frankel, P. Pavlidis, J. Barasch, V. D. D'Agati, and A. G. Gharavi
A Mendelian locus on chromosome 16 determines susceptibility to doxorubicin nephropathy in the mouse
PNAS, February 15, 2005; 102(7): 2502 - 2507.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. Schulz, D. Standke, L. Kovacevic, M. Mostler, P. Kossmehl, M. Stoll, and R. Kreutz
A Major Gene Locus Links Early Onset Albuminuria with Renal Interstitial Fibrosis in the MWF Rat with Polygenetic Albuminuria
J. Am. Soc. Nephrol., December 1, 2003; 14(12): 3081 - 3089.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
L. M. Guay-Woodford
Murine models of polycystic kidney disease: molecular and therapeutic insights
Am J Physiol Renal Physiol, December 1, 2003; 285(6): F1034 - F1049.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A.-K. Siegel, M. Planert, S. Rademacher, A. P. Mehr, P. Kossmehl, M. Wehland, M. Stoll, and R. Kreutz
Genetic Loci Contribute to the Progression of Vascular and Cardiac Hypertrophy in Salt-Sensitive Spontaneous Hypertension
Arterioscler. Thromb. Vasc. Biol., July 1, 2003; 23(7): 1211 - 1217.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.